News

Filter by year:

Filter by tags:

4/06/2021

The 20(+1) under 40: Inside the next generation of biotech leaders

Dr. Juliette Hordeaux, Senior Research Director at GTP is featured in Endpoints News’ annual “Under 40: Inside the next generation of biotech leaders.”

2/11/2021

The Future of Rare Disease Research: Ethics, Treatments, and Access

In conjunction with the tenth anniversary of the Penn Orphan Disease Center (ODC), Penn Medicine will host a two-day symposium featuring ODC Director James Wilson, NIH Director Francis Collins, former Prime Minister David Cameron and others on February 24th & 25th

2/09/2021

America's Best Large Employers

We are excited to share that the University of Pennsylvania and Penn Medicine are both ranked in the Top 100 among America's Best Large Employers 2021 by Forbes!

1/29/2021

AAVCOVID single-dose, room temperature-stable COVID-19 vaccine supported by new funding

Up to $2.1 million award from the Bill & Melinda Gates Foundation to enable AAVCOVID platform, with single-dose vaccines that can be stored at room temperature for up to one month, to enter phase I clinical trials overseas

12/18/2020

Repurposing a proven gene therapy approach to treat, prevent COVID-19

In a Q&A, Penn Medicine’s James M. Wilson discusses using adeno-associated viral vectors to transport a lab-made antibody cocktail into the body. This method, delivered via nasal spray or mist, has the potential to act as a ‘bioshield’ against SARS-CoV-2.

11/30/2020

Penn Medicine Collaborates with Regeneron to Investigate Delivery of COVID-19 Antibody Cocktail via Gene Therapy Platform

Gene Therapy Pioneer James Wilson leading studies of adeno-associated viral vectors to potentially prevent COVID-19